The different roles of hRAD50 in microsatellite stable and unstable colorectal cancers

Disease Markers

Volumn 24, Issue 2, 2008, Pages 127-134

  Gao, Jingfang ^a   Zhang, Hong ^a   Arbman, Gunnar ^b   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Surgery ^*  (Sweden)

Author keywords

Colorectal cancer; HRAD50; Immunohistochemistry; Microsatellite instability; Microsatellite stability

Indexed keywords

DNA; PROTEIN HRAD50; RAD50 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CELL INFILTRATION; COLORECTAL CANCER; DNA REPAIR; DNA SEQUENCE; DNA STRAND BREAKAGE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 38349085283     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/724796     Document Type: Article

References (18)

1. H. Rajagopalan, M.A. Nowak, B. Vogelstein and C. Lengauer, The significance of unstable chromosomes in colorectal cancer, Nat Rev Cancer 3 (2003), 695-701.
2. N. Assenmacher and K.P. Hopfner, MRE11/RAD50/NBS1: complex activities, Chromosoma 113 (2004), 157-166.
3. G. Luo, M.S. Yao, C.F. Bender, M. Mills, A.R. Bladl, A. Bradley and J.H. Petrini, Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation, Proc Natl Acad Sci USA 96 (1996), 7376-7381.
4. C.F. Bender, M.L. Sikes, R. Sullivan, L.E. Huye, M.M. Le Beau, D.B. Roth, O.K. Mirzoeva, E.M. Oltz and J.H. Petrini, Cancer predisposition and haematopoietic failure in Rad50(S/S) mice, Genes Dev 16 (2002), 2237-2251.
5. B.A. Shin, K.Y. Ahn, H. Kook, J.T. Koh, I.C. Kang, H.C. Lee and K.K. Kim, Overexpressed human RAD50 exhibits cell death in a p21 (WAF1/CIP1)-dependent manner: its potential utility in local gene therapy of tumour, Cell Growth Differ 12 (2001), 243-254.
6. T. Ikenoue, G. Togo, K. Nagai, H. Ijichi, J. Kato, Y. Yamaji, M. Okamoto, N. Kato, T. Kawabe, A. Tanaka, M. Matsumura, Y. Shiratori and M. Omata, Frameshift mutations at mononucleotide repeats in RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability, Jpn J Cancer Res 92 (2001), 587-591.
7. N.G. Kim, Y.R. Choi, M.J. Baek, Y.H. Kim, H. Kang, N.K. Kim, J.S. Min and H. Kim, Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability, Cancer Res 61 (2001), 36-38.
8. A. Duval, S. Rolland, A. Compoint, E. Tubacher, B. Iacopetta, G. Thomas and R. Hamelin, Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers, Hum Mol Genet 10 (2001), 513-518.
9. K.H. Koh, H.J. Kang, L.S. Li, N.G. Kim, K.T. You, E. Yang, H. Kim, H.J. Kim, C.O. Yun, K.S. Kim and H. Kim, Impaired nonhomologous end-joining in mismatch repairdeficient colon carcinomas, Lab Invest 85 (2005), 1130-1138.
10. J.F. Gao, G. Arbman, I. Wadhra, H. Zhang and X.F. Sun, The relationship of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancer, World J Gastroenterol 11 (2005), 2179-2183.
11. A. Emterling, A. Wallin, G. Arbman and X.F. Sun, Clinico-pathological significance of microsatellite instability and mutated RIZ in colorectal cancer, Ann Oncol 15 (2004), 242-246.
12. S. Evertson, A. Wallin, G. Arbman, S. Rutten, A. Emterling, H. Zhang and X.F. Sun, Microsatellite instability and MBD4 mutation in unselected colorectal cancer, Anticancer Res 23 (2003), 3569-3574.
13. X.F. Sun, J.M. Carstensen, H. Zhang, G. Arbman and B. Nordenskjold, Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas, Eur J Cancer 32 (1996), 1963-1967.
14. Z. Bartik, B. Nordenskjold and X.F. Sun, p53 overexpression as a prognostic factor in patients with Dukes B colorectal adenocarcinoma, Int J Oncol 11 (1997), 1019-1123.
15. H. Zhang, Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma, Clin Cancer Res 5 (1999), 4126-4132.
16. J. Bartkova, Z. Horejsi, K.Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J.M. Nesland, C. Lukas, T. Orntoft, J. Lukas and J. Bartek, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature 434 (2005), 864-870.
17. T.T. Paull and J.H. Lee, The Mre11/Rad50/Nbs1 complex and its role as a DNA double-strand break sensor for ATM, Cell Cycle 4 (2005), 737-740.
18. R.A. DiTullio Jr, T.A. Mochan, M. Venere, J. Bartkova, M. Sehested, J. Bartek and T.D. Halazonetis, 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer, Nat Cell Biol 4 (2002), 998-1002.